Ceci Connolly, president and CEO of the Alliance for Community Health Plans, told Fierce Healthcare in an email that given some alarming adverse events and the steep price tag, ACHP and our member companies are focused on ensuring prescribing decisions are based on science as well as on providing patients with the best care possible. David Allen, a spokesperson for AHIP, echoed Connolly in an email to Fierce Healthcare, saying that insurers routinely review treatments for obesity, including lifestyle changes and nutrition counseling
2006), desempea un papel importante en la cetognesis por su aporte de acetil-CoA (Stephens et al
Hypercobalaminemia Induced by an Energy Drink after Total Gastrectomy: A Case Report
Variants associated with greater insulin resistance or weight gain susceptibility support clinical narratives emphasizing metabolic disease rather than cosmetic weight loss
Originally developed for diabetes management, semaglutide received FDA approval for chronic weight management in adults with BMI 30 kg/m or BMI 27 kg/m with weight-related medical conditions
Ozempic has undergone thorough research, with the product shown to significantly be effective at reducing blood sugar and aiding weight loss
